- Home
- ENTA vs VPG Comparison
ENTA vs VPG Comparison
Compare ENTA & VPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTA
- VPG
- Stock Information
- Founded
- ENTA 1995
- VPG 2009
- Country
- ENTA United States
- VPG United States
- Employees
- ENTA N/A
- VPG N/A
- Industry
- ENTA Biotechnology: Pharmaceutical Preparations
- VPG Electrical Products
- Sector
- ENTA Health Care
- VPG Technology
- Exchange
- ENTA Nasdaq
- VPG Nasdaq
- Market Cap
- ENTA 245.4M
- VPG 283.7M
- IPO Year
- ENTA 2013
- VPG N/A
- Fundamental
- Price
- ENTA $9.31
- VPG $21.65
- Analyst Decision
- ENTA Buy
- VPG Hold
- Analyst Count
- ENTA 3
- VPG 1
- Target Price
- ENTA $19.67
- VPG $31.00
- AVG Volume (30 Days)
- ENTA 114.1K
- VPG 94.9K
- Earning Date
- ENTA 11-25-2024
- VPG 11-05-2024
- Dividend Yield
- ENTA N/A
- VPG N/A
- EPS Growth
- ENTA N/A
- VPG N/A
- EPS
- ENTA N/A
- VPG 0.99
- Revenue
- ENTA $71,960,000.00
- VPG $323,397,000.00
- Revenue This Year
- ENTA N/A
- VPG N/A
- Revenue Next Year
- ENTA $5.14
- VPG $1.31
- P/E Ratio
- ENTA N/A
- VPG $21.88
- Revenue Growth
- ENTA N/A
- VPG N/A
- 52 Week Low
- ENTA $8.51
- VPG $20.83
- 52 Week High
- ENTA $17.80
- VPG $35.98
- Technical
- Relative Strength Index (RSI)
- ENTA 28.86
- VPG 39.04
- Support Level
- ENTA $10.84
- VPG $20.83
- Resistance Level
- ENTA $10.89
- VPG $24.29
- Average True Range (ATR)
- ENTA 0.49
- VPG 0.71
- MACD
- ENTA -0.19
- VPG -0.06
- Stochastic Oscillator
- ENTA 18.18
- VPG 23.70
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company focused on the research and development of molecule drugs to cure viral infections and liver diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.
About VPG Vishay Precision Group Inc.
Vishay Precision Group Inc manufactures and markets sensors, and sensor-based measurement systems, as well as specialty resistors and strain gages based on proprietary technology. The company provides precision products and solutions, many of which are designed-in by customers, specializing in the growing markets of stress, force, weight, pressure, and current measurements. The company reports in three product segments: Sensors segment, Weighing Solutions segment, and Measurement Systems segment. It has a business presence in the United States and other countries. It generates majority of its revenue from United States.